Nifty
Sensex
:
:
15746.45
52578.76
-78.00 (-0.49%)
-316.65 (-0.60%)

Pharmaceuticals & Drugs

Rating :
67/99

BSE: 524654 | NSE: Not Listed

165.30
26-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  172.40
  •  172.40
  •  162.05
  •  165.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  130
  •  14.97
  •  188.50
  •  43.90

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 103.03
  • 14.90
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 110.47
  • 0.61%
  • 1.66

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.37%
  • 0.00%
  • 32.02%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 13.61%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.15
  • 8.19
  • 9.97

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.17
  • 16.76
  • 17.06

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.20
  • 61.63
  • 53.25

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 15.60
  • 15.93

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.32
  • 0.78
  • 0.85

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.63
  • 6.39
  • 7.06

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
23.12
15.65
47.73%
21.75
16.37
32.86%
18.65
15.52
20.17%
16.00
14.02
14.12%
Expenses
19.61
14.14
38.68%
18.38
14.74
24.69%
16.21
14.60
11.03%
14.40
12.79
12.59%
EBITDA
3.51
1.51
132.45%
3.37
1.63
106.75%
2.44
0.92
165.22%
1.60
1.23
30.08%
EBIDTM
15.18%
9.65%
15.49%
9.96%
13.14%
5.93%
10.00%
8.77%
Other Income
0.20
0.21
-4.76%
0.01
0.22
-95.45%
0.17
0.26
-34.62%
0.34
0.27
25.93%
Interest
0.16
0.19
-15.79%
0.03
0.27
-88.89%
0.04
0.16
-75.00%
0.15
0.15
0.00%
Depreciation
1.13
1.32
-14.39%
1.09
1.15
-5.22%
1.05
0.75
40.00%
1.03
0.90
14.44%
PBT
2.42
0.21
1,052.38%
2.26
0.43
425.58%
1.53
0.27
466.67%
2.94
0.45
553.33%
Tax
0.79
0.10
690.00%
0.64
0.20
220.00%
0.35
0.12
191.67%
0.46
0.10
360.00%
PAT
1.63
0.11
1,381.82%
1.62
0.23
604.35%
1.18
0.15
686.67%
2.48
0.35
608.57%
PATM
7.05%
0.70%
7.45%
1.41%
6.33%
0.97%
15.50%
2.50%
EPS
2.62
0.18
1,355.56%
2.60
0.37
602.70%
1.91
0.24
695.83%
3.98
0.56
610.71%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Net Sales
-
79.51
61.55
59.78
54.76
Net Sales Growth
-
29.18%
2.96%
9.17%
 
Cost Of Goods Sold
-
37.43
28.03
26.49
23.81
Gross Profit
-
42.09
33.52
33.29
30.95
GP Margin
-
52.94%
54.46%
55.69%
56.52%
Total Expenditure
-
68.41
56.11
54.73
49.22
Power & Fuel Cost
-
8.51
8.16
8.89
6.79
% Of Sales
-
10.70%
13.26%
14.87%
12.40%
Employee Cost
-
6.97
5.91
5.57
5.23
% Of Sales
-
8.77%
9.60%
9.32%
9.55%
Manufacturing Exp.
-
5.44
5.56
5.92
4.80
% Of Sales
-
6.84%
9.03%
9.90%
8.77%
General & Admin Exp.
-
3.13
3.51
3.63
3.07
% Of Sales
-
3.94%
5.70%
6.07%
5.61%
Selling & Distn. Exp.
-
5.65
4.46
3.92
5.20
% Of Sales
-
7.11%
7.25%
6.56%
9.50%
Miscellaneous Exp.
-
1.29
0.49
0.30
0.32
% Of Sales
-
1.62%
0.80%
0.50%
0.58%
EBITDA
-
11.10
5.44
5.05
5.54
EBITDA Margin
-
13.96%
8.84%
8.45%
10.12%
Other Income
-
0.73
0.95
1.14
0.81
Interest
-
0.54
0.91
0.53
0.33
Depreciation
-
4.31
4.12
3.20
4.33
PBT
-
6.98
1.37
2.46
1.68
Tax
-
2.24
0.51
0.15
0.57
Tax Rate
-
24.45%
37.23%
7.25%
33.93%
PAT
-
6.91
0.86
1.92
1.11
PAT before Minority Interest
-
6.91
0.86
1.92
1.11
Minority Interest
-
0.00
0.00
0.00
0.00
PAT Margin
-
8.69%
1.40%
3.21%
2.03%
PAT Growth
-
703.49%
-55.21%
72.97%
 
EPS
-
11.15
1.39
3.10
1.79

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 21
Mar 20
Mar 19
Mar 18
Shareholder's Funds
62.10
55.62
55.49
54.32
Share Capital
6.23
6.23
6.23
6.23
Total Reserves
55.86
49.39
49.26
48.09
Non-Current Liabilities
1.08
1.08
1.23
1.88
Secured Loans
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
Long Term Provisions
0.12
0.14
0.15
0.15
Current Liabilities
33.87
17.99
16.42
14.86
Trade Payables
16.33
6.96
8.25
12.05
Other Current Liabilities
6.89
4.65
2.63
1.84
Short Term Borrowings
9.63
6.26
5.41
0.00
Short Term Provisions
1.02
0.11
0.13
0.96
Total Liabilities
97.05
74.69
73.14
71.06
Net Block
38.11
23.81
24.37
21.88
Gross Block
86.92
69.64
66.07
61.49
Accumulated Depreciation
48.81
45.83
41.71
39.61
Non Current Assets
55.10
36.98
34.79
29.42
Capital Work in Progress
6.98
2.11
2.45
1.03
Non Current Investment
0.00
5.57
5.07
5.07
Long Term Loans & Adv.
9.23
4.69
2.09
0.48
Other Non Current Assets
0.79
0.79
0.81
0.96
Current Assets
41.94
37.71
38.36
41.64
Current Investments
0.00
0.00
0.00
0.00
Inventories
6.61
5.28
4.32
7.70
Sundry Debtors
26.70
30.36
32.20
31.26
Cash & Bank
2.18
0.93
0.50
0.91
Other Current Assets
6.46
0.10
0.07
0.22
Short Term Loans & Adv.
5.76
1.04
1.27
1.54
Net Current Assets
8.07
19.72
21.94
26.78
Total Assets
97.04
74.69
73.15
71.06

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 21
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
12.60
7.20
2.10
5.35
PBT
9.16
1.37
2.07
1.68
Adjustment
2.73
5.03
3.89
4.58
Changes in Working Capital
2.93
1.46
-3.07
-0.92
Cash after chg. in Working capital
14.82
7.86
2.89
5.35
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-2.22
-0.66
-0.79
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-15.58
-5.74
-7.06
-0.93
Net Fixed Assets
-15.10
-3.23
-6.00
Net Investments
5.56
-0.50
-0.01
Others
-6.04
-2.01
-1.05
Cash from Financing Activity
2.75
-1.19
4.28
-3.93
Net Cash Inflow / Outflow
-0.23
0.27
-0.68
0.49
Opening Cash & Equivalents
0.33
0.06
0.74
0.25
Closing Cash & Equivalent
0.10
0.33
0.06
0.74

Financial Ratios

Standalone /

Consolidated
Description
Mar 21
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
99.63
89.24
89.04
87.16
ROA
8.05%
1.16%
2.66%
1.56%
ROE
11.74%
1.54%
3.50%
2.05%
ROCE
14.52%
3.71%
4.51%
3.71%
Fixed Asset Turnover
1.02
0.91
0.94
0.89
Receivable days
130.95
185.47
193.73
208.38
Inventory Days
27.29
28.45
36.68
51.33
Payable days
62.19
48.48
69.74
83.44
Cash Conversion Cycle
96.05
165.44
160.67
176.26
Total Debt/Equity
0.16
0.11
0.10
0.00
Interest Cover
17.84
2.51
4.90
6.03

News Update:


  • Natural Capsules gets nod for capacity expansion plan
    16th Jul 2021, 10:17 AM

    The Board of Directors of the company in the meeting held on July 15, 2021 has approved the same

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.